7 Best Stocks for the Next 30 Days

Get them in a free Special Report, and get more Zacks Insights in our free e-newsletter, Profit from the Pros. Every issue includes a fresh Zacks #1 Bull Stock of the Day.

Close This Panel X

Are you a new Zacks Member or a visitor to Zacks.com?

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Stocks on the Move 05/22/2013

Company Name Symbol %Change
ALLIANCE FIB AFOP
9.31%
SONIC FOUNDR SOFO
7.77%
VELTI PLC OR VELT
7.58%
TRI TECH HOL TRIT
6.62%
A M R CP AAMRQ
4.52%

Corning Closes BD Labware Unit Buy

by Zacks Equity Research

November 02, 2012 | Comments : 0 Recommended this article: (0)

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

Corning Inc. ( GLW - Analyst Report ) recently completed its acquisition of the majority portion of the Discovery Labware unit from Becton, Dickinson & Co. ( BDX - Analyst Report ) . The company spent $720 million in cash for the acquisition. The deal was announced in the month of April.

The Discovery Labware unit has operations in Massachusetts and North Carolina in the United States, and in the United Kingdom, as well as extensive dealer networks in Asia, Europe and North America.

Corning will now integrate four of the Discovery Labware unit's main product platforms into Corning's Life Sciences segment. These product platforms include plastic consumable labware, liquid-handling products, cell-based assays and cell cultureware, as well as ADME research.

The company said that the acquisition will enhance Corning’s broad portfolio of life sciences products and expand its annual revenues by 40%. In the third quarter, Corning’s Life Sciences business accounted for around 8% of revenue, which was down 4.3% sequentially but up 1.3% from a year ago.

The deal will help Corning to expand its global market share and benefit from Discovery Labware unit's extensive product portfolio and established dealer network. In December last year, Corning acquired Mediatech, which was also integrated into Corning's Life Sciences segment to augment its sales.

Corning’s innovations, technologies and acquisitions help it to deliver improved results and maintain its position in an increasingly competitive market. In the last-reported third quarter of 2012, the company’s earnings beat the Zacks Consensus Estimate by 2 cents or 7.1%. Revenues in the quarter were $2.04 billion, up 6.8% sequentially and down 1.8% year over year.

Corningdoes not expect the acquisition to have any impact on its 2012 financials, but believes that the transaction will be slightly accretive in 2013. Additionally, the company stated that the acquisition will aid in achieving its $10 billion revenue target in the next few years.

However, Corning faces significant competition due to market saturation, pricing pressure and product launches. For its hardware and equipment products, the company faces stiff competition from the likes of 3M Company ( MMM - Analyst Report ) , Tyco Electronics, Ltd. ( TEL - Snapshot Report ) , Furukawa OFS, CommScope and ADC Communications.

Corning shares currently carry a Zacks #3 Rank, which translates into a Hold rating for the short term (1–3 months).

Email Print Share Rate Pos Rate Neg

Read/Post Comments (0) | Recommended this article (0)

Please login to Zacks.com or register to post a comment.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.